 |
Page History
...
- As a rule, Subject IDs must be unique across all sites participating in the same trial. In the event that two or more participating sites used the same Subject ID for different subjects in a given trial, Super Abstractors can grant an exception to the rule by flagging the trial.
- By default, the system uses Twitter to inform the public when each NCI-sponsored trial begins to accept patients. For details, refer to About Automatic Tweets. Super Abstractors can suppress these tweets for a particular trial by flagging that trial.
...
